Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

VitaNova Life Sciences (YJGJ) Operating Margin (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Operating Margin for 6 consecutive years, with 23.22% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin rose 179.0% year-over-year to 23.22%, compared with a TTM value of 45.04% through Oct 2025, up 1871.0%, and an annual FY2025 reading of 45.39%, up 936.0% over the prior year.
  • Operating Margin was 23.22% for Q4 2025 at VitaNova Life Sciences, up from 31.22% in the prior quarter.
  • Across five years, Operating Margin topped out at 83.91% in Q1 2022 and bottomed at 66.65% in Q4 2021.
  • Average Operating Margin over 4 years is 13.63%, with a median of 22.11% recorded in 2024.
  • Peak annual rise in Operating Margin hit 1268bps in 2025, while the deepest fall reached 179bps in 2025.
  • Year by year, Operating Margin stood at 66.65% in 2021, then surged by 121bps to 14.23% in 2022, then soared by 51bps to 21.43% in 2024, then increased by 8bps to 23.22% in 2025.
  • Business Quant data shows Operating Margin for YJGJ at 23.22% in Q4 2025, 31.22% in Q3 2025, and 55.41% in Q2 2025.